Found: 37
Select item for more details and to access through your institution.
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 737, doi. 10.1007/s00432-014-1626-2
- By:
- Publication type:
- Article
The Role of CXCL13 and CXCL9 in Early Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Imatinib in the treatment of dermatofibrosarcoma protuberans.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 4, p. 347
- By:
- Publication type:
- Article
Treatment adherence of cancer patients to orally administered chemotherapy: Insights from a Greek study using a self-reported questionnaire.
- Published in:
- Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 4, p. 304, doi. 10.1177/1078155210380292
- By:
- Publication type:
- Article
Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069256
- By:
- Publication type:
- Article
Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3646, doi. 10.3390/cancers14153646
- By:
- Publication type:
- Article
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4621, doi. 10.3390/cancers13184621
- By:
- Publication type:
- Article
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 107, n. 3, p. 431
- By:
- Publication type:
- Article
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 92, n. 1, p. 1, doi. 10.1007/s10549-005-0322-y
- By:
- Publication type:
- Article
Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 77, doi. 10.1186/1756-9966-31-77
- By:
- Publication type:
- Article
p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 2, p. 273, doi. 10.1007/s12253-014-9818-2
- By:
- Publication type:
- Article
Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Prognostic Role of Ephrin A2 and Endothelia Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 267, doi. 10.1016/j.clcc.2013.07.001
- By:
- Publication type:
- Article
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1289, doi. 10.1007/s00280-015-2762-3
- By:
- Publication type:
- Article
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163138
- By:
- Publication type:
- Article
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients.
- Published in:
- Oral, 2023, v. 3, n. 1, p. 123, doi. 10.3390/oral3010011
- By:
- Publication type:
- Article
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- Journal of Neuro-Oncology, 2017, v. 134, n. 2, p. 443, doi. 10.1007/s11060-017-2548-z
- By:
- Publication type:
- Article
Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer.
- Published in:
- Oncology, 2009, v. 76, n. 4, p. 275, doi. 10.1159/000207504
- By:
- Publication type:
- Article
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 835, doi. 10.1002/onco.13855
- By:
- Publication type:
- Article
BRCAness: Finding the Achilles Heel in Ovarian Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. 956, doi. 10.1634/theoncologist.2012-0028
- By:
- Publication type:
- Article
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
- Published in:
- Oncology Letters, 2022, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents.
- Published in:
- Oral Diseases, 2020, v. 26, n. 5, p. 955, doi. 10.1111/odi.13294
- By:
- Publication type:
- Article
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 7, p. 1200, doi. 10.1093/neuonc/noad038
- By:
- Publication type:
- Article
A Tongue Lesion as a Sign of a Systemic Disease.
- Published in:
- Case Reports in Medicine, 2016, p. 1, doi. 10.1155/2016/6723575
- By:
- Publication type:
- Article
Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.
- Published in:
- Journal of Oncology, 2010, p. 1, doi. 10.1155/2010/709678
- By:
- Publication type:
- Article
Incidence and Treatment of Tumor Lysis Syndrome in Patients with Acute Leukemia.
- Published in:
- Acta Haematologica, 1994, v. 91, n. 4, p. 171, doi. 10.1159/000204328
- By:
- Publication type:
- Article
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0207707
- By:
- Publication type:
- Article
Clinical Presentation, Diagnosis, and Radiological Findings of Neoplastic Meningitis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-111
- By:
- Publication type:
- Article
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-49
- By:
- Publication type:
- Article
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-234
- By:
- Publication type:
- Article